These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 33642053)
1. Dysregulation of miR-638 in the progression of cancers. Chong ZX; Yeap SK; Ho WY Pathol Res Pract; 2021 Apr; 220():153351. PubMed ID: 33642053 [TBL] [Abstract][Full Text] [Related]
2. Unveiling the tumour-regulatory roles of miR-1275 in cancer. Chong ZX; Yeap SK; Ho WY; Fang CM Pathol Res Pract; 2022 Feb; 230():153745. PubMed ID: 34953353 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-217: A regulator of human cancer. Zhou S; Zhu C; Pang Q; Liu HC Biomed Pharmacother; 2021 Jan; 133():110943. PubMed ID: 33254014 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-129 in Human Cancers: from Tumorigenesis to Clinical Treatment. Gao Y; Feng B; Han S; Lu L; Chen Y; Chu X; Wang R; Chen L Cell Physiol Biochem; 2016; 39(6):2186-2202. PubMed ID: 27802440 [TBL] [Abstract][Full Text] [Related]
5. Functional mechanism and clinical implications of MicroRNA-423 in human cancers. Ke R; Lv L; Zhang S; Zhang F; Jiang Y Cancer Med; 2020 Dec; 9(23):9036-9051. PubMed ID: 33174687 [TBL] [Abstract][Full Text] [Related]
6. Recent trends in targeting miRNAs for cancer therapy. Shah V; Shah J J Pharm Pharmacol; 2020 Dec; 72(12):1732-1749. PubMed ID: 32783235 [TBL] [Abstract][Full Text] [Related]
7. The Regulatory Mechanism of miR-574-5p Expression in Cancer. Huang W; Zhao Y; Xu Z; Wu X; Qiao M; Zhu Z; Zhao Z Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671425 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic targeting of miRNA-216b in cancer. Jana S; Krishna M; Singhal J; Horne D; Awasthi S; Salgia R; Singhal SS Cancer Lett; 2020 Aug; 484():16-28. PubMed ID: 32387443 [TBL] [Abstract][Full Text] [Related]
9. MiRNA-145 and Its Direct Downstream Targets in Digestive System Cancers: A Promising Therapeutic Target. Ma Y; Cao X; Shi G; Shi T Curr Pharm Des; 2021; 27(19):2264-2273. PubMed ID: 33121400 [TBL] [Abstract][Full Text] [Related]
10. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy. Humphries B; Yang C Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624 [TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of microRNAs in regulating epithelial-mesenchymal transitions in human cancers. Tang J; Li Y; Wang J; Wen Z; Lai M; Zhang H Cancer Lett; 2016 Feb; 371(2):301-13. PubMed ID: 26683775 [TBL] [Abstract][Full Text] [Related]
12. The miR-15a/16 gene cluster in human cancer: A systematic review. Liu T; Xu Z; Ou D; Liu J; Zhang J J Cell Physiol; 2019 May; 234(5):5496-5506. PubMed ID: 30246332 [TBL] [Abstract][Full Text] [Related]
13. MicroRNAs: biogenesis, roles for carcinogenesis and as potential biomarkers for cancer diagnosis and prognosis. Kavitha N; Vijayarathna S; Jothy SL; Oon CE; Chen Y; Kanwar JR; Sasidharan S Asian Pac J Cancer Prev; 2014; 15(18):7489-97. PubMed ID: 25292018 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-224: as a potential target for miR-based therapy of cancer. Chen W; Fan XM; Mao L; Zhang JY; Li J; Wu JZ; Tang JH Tumour Biol; 2015 Sep; 36(9):6645-52. PubMed ID: 26254100 [TBL] [Abstract][Full Text] [Related]
15. miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer. Chakrabortty A; Patton DJ; Smith BF; Agarwal P Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510280 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-375: potential cancer suppressor and therapeutic drug. Wei J; Lu Y; Wang R; Xu X; Liu Q; He S; Pan H; Liu X; Yuan B; Ding Y; Zhang J Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34494089 [TBL] [Abstract][Full Text] [Related]
17. Tumor-Progressive Mechanisms Mediating miRNA-Protein Interaction. Konishi H; Sato H; Takahashi K; Fujiya M Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830186 [TBL] [Abstract][Full Text] [Related]
18. The role of miR-153 and related upstream/downstream pathways in cancers: from a potential biomarker to treatment of tumor resistance and a therapeutic target. Alamdari-Palangi V; Jaberi KR; Jaberi AR; Gheibihayat SM; Akbarzadeh M; Tajbakhsh A; Savardashtaki A Med Oncol; 2022 Apr; 39(5):62. PubMed ID: 35477802 [TBL] [Abstract][Full Text] [Related]
19. Emerging microRNAs in cancer diagnosis, progression, and immune surveillance. Harrandah AM; Mora RA; Chan EKL Cancer Lett; 2018 Dec; 438():126-132. PubMed ID: 30237038 [TBL] [Abstract][Full Text] [Related]
20. miR-939, as an important regulator in various cancers pathogenesis, has diagnostic, prognostic, and therapeutic values: a review. Kouchaki H; Kamyab P; Darbeheshti F; Gharezade A; Fouladseresht H; Tabrizi R J Egypt Natl Canc Inst; 2024 Apr; 36(1):16. PubMed ID: 38679648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]